Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunoperoxidase localization of prostate-specific antigen.

B S Stein, S Vangore, R O Petersen

    The American Journal of Surgical Pathology
    |September 1, 1982
    PubMed
    Summary

    Prostate-specific antigen (PSA) is a useful marker for identifying prostate cancer. However, poorly differentiated tumors may lack PSA, meaning its absence does not rule out prostate carcinoma.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Outcome following treatment of soft tissue and visceral extraskeletal osteosarcoma in 33 dogs: 2008-2013.

    Veterinary and comparative oncology·2015
    Same author

    A comparison of dual energy X-ray absorptiometry of the hip and accuDEXA of the finger for the diagnosis of osteoporosis in men on androgen deprivation therapy for advanced prostate cancer.

    Prostate cancer and prostatic diseases·2006
    Same author

    Capturing the circadian rhythms of free-running blind people with 0.5 mg melatonin.

    Brain research·2001
    Same author

    Effects of aging on the intrinsic circadian period of totally blind humans.

    Journal of biological rhythms·2001
    Same author

    Entrainment of free-running circadian rhythms by melatonin in blind people.

    The New England journal of medicine·2000
    Same author

    The efficacy of early adjuvant radiation therapy for pT3N0 prostate cancer: a matched-pair analysis.

    International journal of radiation oncology, biology, physics·1999

    Area of Science:

    • Oncology
    • Pathology
    • Urology

    Background:

    • Metastatic tumors of unknown primary require accurate identification.
    • Distinguishing prostate carcinoma is crucial for effective treatment.
    • Prostate-specific antigen (PSA) is a potential biomarker for prostate cancer.

    Purpose of the Study:

    • To evaluate the reliability of immunoperoxidase localization of PSA in prostate carcinoma.
    • To determine the correlation between PSA presence and tumor grade (Gleason score).

    Main Methods:

    • Studied 15 prostate carcinoma specimens from 14 patients.
    • Utilized immunoperoxidase techniques for PSA detection.
    • Correlated PSA staining intensity with Gleason grades.

    Related Experiment Videos

    Main Results:

    • PSA presence correlated with Gleason grade.
    • All Gleason grades 9 or less showed strong PSA staining.
    • 57% of Gleason grade 10 specimens showed significant PSA staining; 2 lacked PSA.

    Conclusions:

    • PSA is a useful marker when detected in prostate carcinoma.
    • Absence of PSA in poorly differentiated tumors does not exclude prostate origin.
    • Further investigation needed for PSA detection in high-grade prostate cancer.